EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 54 / No 4 (December 2022) J Extra Corpor Technol, 54 4 (2022) 267-290 References
Free Access
Issue
J Extra Corpor Technol
Volume 54, Number 4, December 2022
Page(s) 267 - 290
DOI https://doi.org/10.1051/ject/202254267
Published online 15 December 2022
  1. Brown JR, Cochran RP, Dacey LJ, et al. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation. 2006;114(suppl):I409–13. [CrossRef] [PubMed] [Google Scholar]
  2. Brown JR, Cochran RP, Leavitt BJ, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116(suppl):I139–43. [Google Scholar]
  3. Vives M, Wijeysundera D, Marczin N, et al. Cardiac surgery-associated acute kidney injury. Interact Cardiovasc Thorac Surg. 2014;18:637–45. [CrossRef] [PubMed] [Google Scholar]
  4. Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (part 1). Crit Care. 2013;17:204. [CrossRef] [PubMed] [Google Scholar]
  5. Brown JR, Kramer RS, Coca SG, et al. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg. 2010;90:1142–8. [CrossRef] [Google Scholar]
  6. Brown JR, Kramer RS, MacKenzie TA, et al. Determinants of acute kidney injury duration after cardiac surgery: An externally validated tool. Ann Thorac Surg. 2012;93:570–6. [CrossRef] [Google Scholar]
  7. Bagshaw SM, George C, Bellomo R. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008;23:1569–74. [CrossRef] [PubMed] [Google Scholar]
  8. Joannidis M, Metnitz B, Bauer P, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009;35:1692–702. [CrossRef] [PubMed] [Google Scholar]
  9. Acute Kidney Injury Work Group. Kidney disease: Improving global outcomes (KDIGO). KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2(suppl 1):1–138. [CrossRef] [Google Scholar]
  10. Nadim MK, Forni LG, Bihorac A, et al. Cardiac and vascular surgery-associated acute kidney injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) group. J Am Heart Assoc. 2018;7:e008834. [CrossRef] [Google Scholar]
  11. Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551–61. Published correction appears in Intensive Care Med. 2017;43:1749. [CrossRef] [PubMed] [Google Scholar]
  12. Aldea GS, Bakaeen FG, Pal J, et al. The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting. Ann Thorac Surg. 2016;101:801–9. [CrossRef] [Google Scholar]
  13. Badhwar V, Rankin JS, Damiano RJ Jr, et al. The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2017;103:329–41. [CrossRef] [Google Scholar]
  14. Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2016;133:1426–8. [CrossRef] [PubMed] [Google Scholar]
  15. Boodhwani M, Rubens FD, Wozny D, et al. Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann Thorac Surg. 2009;87:489–95. [CrossRef] [Google Scholar]
  16. Newland RF, Tully PJ, Baker RA. Hyperthermic perfusion during cardiopulmonary bypass and postoperative temperature are independent predictors of acute kidney injury following cardiac surgery. Perfusion. 2013;28:223–31. [CrossRef] [PubMed] [Google Scholar]
  17. Newland RF, Baker RA, Mazzone AL, et al. Rewarming temperature during cardiopulmonary bypass and acute kidney injury: A multicenter analysis. Ann Thorac Surg. 2016;101:1655–62. [CrossRef] [Google Scholar]
  18. Ranucci M, Romitti F, Isgro G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005;80:2213–20. [CrossRef] [Google Scholar]
  19. Newland RF, Baker RA. Low oxygen delivery as a predictor of acute kidney injury during cardiopulmonary bypass. J Extra Corpor Technol. 2017;49:224–30. [Google Scholar]
  20. Mukaida H, Matsushita S, Kuwaki K, et al. Time-dose response of oxygen delivery during cardiopulmonary bypass predicts acute kidney injury. J Thorac Cardiovasc Surg. 2019;158:492–9. [CrossRef] [Google Scholar]
  21. Ranucci M, Johnson I, Willcox T, et al. Goal-directed perfusion to reduce acute kidney injury: A randomized trial. J Thorac Cardiovasc Surg. 2018;156:1918–27.e1912. [CrossRef] [Google Scholar]
  22. Newland RF, Baker RA, Woodman RJ, et al. Predictive capacity of oxygen delivery during cardiopulmonary bypass on acute kidney injury. Ann Thorac Surg. 2019;108:1807–14. [CrossRef] [Google Scholar]
  23. Anastasiadis K, Murkin J, Antonitsis P, et al. Use of minimal invasive extracorporeal circulation in cardiac surgery: Principles, definitions and potential benefits. A position paper from the Minimal Invasive Extra-Corporeal Technologies International Society (MiECTiS). Interact Cardiovasc Thorac Surg. 2016;22:647–62. [CrossRef] [PubMed] [Google Scholar]
  24. Sun Y, Gong B, Yuan X, et al. What we have learned about minimized extracorporeal circulation versus conventional extracorporeal circulation: An updated meta-analysis. Int J Artif Organs. 2015;38:444–53. [CrossRef] [PubMed] [Google Scholar]
  25. Kowalewski M, Pawliszak W, Raffa GM, et al. Safety and efficacy of miniaturized extracorporeal circulation when compared with off-pump and conventional coronary artery bypass grafting: Evidence synthesis from a comprehensive Bayesian-framework network meta-analysis of 134 randomized controlled trials involving 22,778 patients. Eur J Cardiothorac Surg. 2016;49:1428–40. [CrossRef] [PubMed] [Google Scholar]
  26. Choi MR, Kouyoumdzian NM, Rukavina Mikusic NL, et al. Renal dopaminergic system: Pathophysiological implications and clinical perspectives. World J Nephrol. 2015;4:196–212. [CrossRef] [Google Scholar]
  27. Patel NN, Rogers CA, Angelini GD, et al. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: A systematic review. Heart Fail Rev. 2011;16:553–67. [CrossRef] [PubMed] [Google Scholar]
  28. Carcoana OV, Mathew JP, Davis E, et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial. Anesth Analg. 2003;97:1222–9. [CrossRef] [PubMed] [Google Scholar]
  29. Dehne MG, Klein TF, Muhling J, et al. Impairment of renal function after cardiopulmonary bypass is not influenced by dopexamine. Ren Fail. 2001;23:217–30. [CrossRef] [PubMed] [Google Scholar]
  30. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97–104. [CrossRef] [PubMed] [Google Scholar]
  31. Sumeray M, Robertson C, Lapsley M, et al. Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery. J Nephrol. 2001;14:397–402. [Google Scholar]
  32. Woo EB, Tang AT, el-Gamel A, et al. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: Science or fiction? Eur J Cardiothorac Surg. 2002;22:106–11. [CrossRef] [PubMed] [Google Scholar]
  33. Yavuz S, Ayabakan N, Dilek K, et al. Renal dose dopamine in open heart surgery. Does it protect renal tubular function? J Cardiovasc Surg (Torino). 2002;43:25–30. [Google Scholar]
  34. Yavuz S, Ayabakan N, Goncu MT, et al. Effect of combined dopamine and diltiazem on renal function after cardiac surgery. Med Sci Monit. 2002;8:PI45–50. [Google Scholar]
  35. Mahesh B, Yim B, Robson D, et al. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomized trial. Eur J Cardiothorac Surg. 2008;33:370–6. [CrossRef] [Google Scholar]
  36. Smith MN, Best D, Sheppard SV, et al. The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction. Anaesthesia. 2008;63:701–4. [CrossRef] [Google Scholar]
  37. Yallop KG, Sheppard SV, Smith DC. The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine. Anaesthesia. 2008;63:576–82. [CrossRef] [PubMed] [Google Scholar]
  38. Bergman AS, Odar-Cederlof I, Westman L, et al. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth. 2002;16:294–9. [CrossRef] [Google Scholar]
  39. Bove T, Landoni G, Calabrò MG, et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial. Circulation. 2005;111:3230–5. [CrossRef] [PubMed] [Google Scholar]
  40. Cogliati AA, Vellutini R, Nardini A, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: A randomized clinical study. J Cardiothorac Vasc Anesth. 2007;21:847–50. [CrossRef] [Google Scholar]
  41. Darcin OT, Zor MH, Sahin V, et al. Effect of iloprost on renal function in patients undergoing coronary artery bypass grafting: A clinical study. Ann Thorac Cardiovasc Surg. 2013;19:12–7. [CrossRef] [PubMed] [Google Scholar]
  42. Kaya K, Oguz M, Akar AR, et al. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: A prospective randomized clinical trial. Eur J Cardiothorac Surg. 2007;31:290–7. [CrossRef] [Google Scholar]
  43. Landoni G, Biondi-Zoccai GG, Marino G, et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: A meta-analysis. J Cardiothorac Vasc Anesth. 2008;22:27–33. [CrossRef] [Google Scholar]
  44. Ranucci M, De Benedetti D, Bianchini C, et al. Effects of fenoldopam infusion in complex cardiac surgical operations: A prospective, randomized, double-blind, placebo-controlled study. Minerva Anestesiol. 2010;76:249–59. [Google Scholar]
  45. Ranucci M, Soro G, Barzaghi N, et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg. 2004;78:1332–7, discussion 1337–8. [CrossRef] [Google Scholar]
  46. Roasio A, Lobreglio R, Santin A, et al. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:23–6. [CrossRef] [Google Scholar]
  47. Flesch M, Knipp S, Kessler G, et al. ARTA: At1-receptor blocker therapy in patients undergoing coronary artery bypass grafting. Clin Res Cardiol. 2009;98:33–43. [CrossRef] [PubMed] [Google Scholar]
  48. Türker H, Dönmez A, Zeyneloğlu P, et al. Effects of enalaprilat infusion on hemodynamics and renal function in patients undergoing cardiac surgery. Anadolu Kardiyol Derg. 2004;4:296–300. [Google Scholar]
  49. Witczak BJ, Hartmann A, Geiran OR, et al. Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine. Eur J Anaesthesiol. 2008;25:319–25. [CrossRef] [PubMed] [Google Scholar]
  50. Sun H, Xie Q, Peng Z. Does fenoldopam protect kidney in cardiac surgery? A systemic review and meta-analysis with trial sequential analysis. Shock. 2019;52:326–33. [CrossRef] [PubMed] [Google Scholar]
  51. Zangrillo A, Biondi-Zoccai GG, Frati E, et al. Fenoldopam and acute renal failure in cardiac surgery: A meta-analysis of randomized placebo-controlled trials. J Cardiothorac Vasc Anesth. 2012;26:407–13. [CrossRef] [Google Scholar]
  52. Engelman DT, Crisafi C, Germain M, et al. Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg. 2020;160:1235–46.e2. [CrossRef] [Google Scholar]
  53. Magruder JT, Crawford TC, Harness HL, et al. A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2017;153:118–25. e111. [CrossRef] [Google Scholar]
  54. Bolcal C, Akay HT, Bingol H, et al. Leukodepletion improves renal function in patients with renal dysfunction undergoing on-pump coronary bypass surgery: A prospective randomized study. Thorac Cardiovasc Surg. 2007;55:89–93. [CrossRef] [PubMed] [Google Scholar]
  55. Rubino AS, Serraino GF, Mariscalco G, et al. Leukocyte depletion during extracorporeal circulation allows better organ protection but does not change hospital outcomes. Ann Thorac Surg. 2011;91:534–40. [CrossRef] [Google Scholar]
  56. Tang AT, Alexiou C, Hsu J, et al. Leukodepletion reduces renal injury in coronary revascularization: A prospective randomized study. Ann Thorac Surg. 2002;74:372–7, discussion 377. [CrossRef] [Google Scholar]
  57. Banbury MK, Kouchoukos NT, Allen KB, et al. Emboli capture using the Embol-X intraaortic filter in cardiac surgery: A multicentered randomized trial of 1,289 patients. Ann Thorac Surg. 2003;76:508–15, discussion 515. [CrossRef] [Google Scholar]
  58. Sirvinskas E, Andrejaitiene J, Raliene L, et al. Cardiopulmonary bypass management and acute renal failure: Risk factors and prognosis. Perfusion. 2008;23:323–7. [CrossRef] [PubMed] [Google Scholar]
  59. Vedel AG, Holmgaard F, Rasmussen LS, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: A randomized controlled trial. Circulation. 2018;137:1770–80. [CrossRef] [PubMed] [Google Scholar]
  60. Svenmarker S, Haggmark S, Jansson E, et al. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome. Scand Cardiovasc J. 2002;36:241–6. [CrossRef] [PubMed] [Google Scholar]
  61. Allen S, McBride WT, Young IS, et al. A clinical, renal and immunological assessment of surface modifying additive treated (smart) cardiopulmonary bypass circuits. Perfusion. 2005;20:255–62. [CrossRef] [PubMed] [Google Scholar]
  62. Mullen JC, Bentley MJ, Gelfand ET, et al. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization. Can J Surg. 2002;45:166–72. [Google Scholar]
  63. Matata BM, Scawn N, Morgan M, et al. A single-center randomized trial of intraoperative zero-balanced ultrafiltration during cardiopulmonary bypass for patients with impaired kidney function undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29:1236–47. [CrossRef] [Google Scholar]
  64. Kiessling AH, Wedde S, Keller H, et al. Pre-filling of the extracorporeal circuit with autologous blood is safe, but not effective in optimizing biocompatibility in high-risk patients. Perfusion. 2012;27:371–7. [CrossRef] [PubMed] [Google Scholar]
  65. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann. 2009;17:368–72. [CrossRef] [PubMed] [Google Scholar]
  66. Kuitunen AH, Hynynen MJ, Vahtera E, et al. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004;98:291–7, table of contents. [CrossRef] [PubMed] [Google Scholar]
  67. Sethi BS, Chauhan S, Bisoi AK, et al. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2014;28:690–7. [CrossRef] [Google Scholar]
  68. Lomivorotov VV, Fominskiy EV, Efremov SM, et al. Infusion of 7.2% NaCl/6% hydroxyethyl starch 200/0.5 in on-pump coronary artery bypass surgery patients: A randomized, single-blind pilot study. Shock. 2014;41:193–9. [CrossRef] [PubMed] [Google Scholar]
  69. Scrascia G, Rotunno C, Nanna D, et al. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems. Perfusion. 2012;27:270–7. [CrossRef] [PubMed] [Google Scholar]
  70. Niranjan G, Asimakopoulos G, Karagounis A, et al. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on-versus off-cardiopulmonary bypass: A randomised trial. Eur J Cardiothorac Surg. 2006;30:271–7. [CrossRef] [Google Scholar]
  71. von Heymann C, Sander M, Foer A, et al. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome—A randomized controlled study [ISRCTN35655335]. Crit Care. 2006;10:R58. [CrossRef] [Google Scholar]
  72. Marathias KP, Vassili M, Robola A, et al. Preoperative intravenous hydration confers renoprotection in patients with chronic kidney disease undergoing cardiac surgery. Artif Organs. 2006;30:615–21. [CrossRef] [PubMed] [Google Scholar]
  73. Karkouti K, Wijeysundera DN, Yau TM, et al. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: An unblinded randomized pilot clinical trial. Anesthesiology. 2012;116:613–21. [CrossRef] [PubMed] [Google Scholar]
  74. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;373:193. [Google Scholar]
  75. Nakamura RE, Vincent JL, Fukushima JT, et al. A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2015;150:1314–20. [CrossRef] [Google Scholar]
  76. Song HK, von Heymann C, Jespersen CM, et al. Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations. Ann Thorac Surg. 2014;97:1630–5. [CrossRef] [Google Scholar]
  77. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation. 1997;96:1641–6. [CrossRef] [PubMed] [Google Scholar]
  78. Gho BC, Schoemaker RG, van den Doel MA, et al. Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 1996;94:2193–200. [CrossRef] [PubMed] [Google Scholar]
  79. Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet. 2009;374:1557–65. [CrossRef] [Google Scholar]
  80. Li L, Li G, Yu C, et al. The role of remote ischemic preconditioning on postoperative kidney injury in patients undergoing cardiac and vascular interventions: A meta-analysis. J Cardiothorac Surg. 2013;8:43. [CrossRef] [Google Scholar]
  81. Hausenloy DJ, Candilio L, Evans R, et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408–17. [CrossRef] [PubMed] [Google Scholar]
  82. Hu Q, Luo W, Huang L, et al. Multiorgan protection of remote ischemic perconditioning in valve replacement surgery. J Surg Res. 2016;200:13–20. [CrossRef] [Google Scholar]
  83. Meybohm P, Bein B, Brosteanu O, et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397–407. [CrossRef] [PubMed] [Google Scholar]
  84. Walsh M, Whitlock R, Garg AX, et al. Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (remote impact): A randomized controlled trial. Can Med Assoc J. 2016;188:329–36. [CrossRef] [PubMed] [Google Scholar]
  85. Choi YS, Shim JK, Kim JC, et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: A randomized controlled trial. J Thorac Cardiovasc Surg. 2011;142:148–54. [CrossRef] [Google Scholar]
  86. Rahman IA, Mascaro JG, Steeds RP, et al. Remote ischemic preconditioning in human coronary artery bypass surgery: From promise to disappointment? Circulation. 2010;122(suppl):S53–9. [CrossRef] [PubMed] [Google Scholar]
  87. Venugopal V, Laing CM, Ludman A, et al. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: A secondary analysis of 2 small randomized trials. Am J Kidney Dis. 2010;56:1043–9. [CrossRef] [Google Scholar]
  88. Young PJ, Dalley P, Garden A, et al. A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol. Basic Res Cardiol. 2012;107:256. [CrossRef] [PubMed] [Google Scholar]
  89. Zarbock A, Schmidt C, Van Aken H, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: A randomized clinical trial. J Am Med Assoc. 2015;313:2133–41. [CrossRef] [PubMed] [Google Scholar]
  90. Zimmerman RF, Ezeanuna PU, Kane JC, et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int. 2011;80:861–7. [CrossRef] [Google Scholar]
  91. Durmaz I, Yagdi T, Calkavur T, et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75:859–64. [CrossRef] [Google Scholar]
  92. Dehne MG, Klein TF, Muhling J, et al. Impairment of renal function after cardiopulmonary bypass is not influenced by dopexamine. Ren Fail. 2001;23:217–30. [CrossRef] [PubMed] [Google Scholar]
  93. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97–104. [CrossRef] [PubMed] [Google Scholar]
  94. Mahesh B, Yim B, Robson D, et al. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg. 2008;33:370–6. [CrossRef] [Google Scholar]
  95. Kaya K, Oguz M, Akar AR, et al. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: A prospective randomized clinical trial. Eur J Cardiothorac Surg. 2007;31:290–7. [CrossRef] [Google Scholar]
  96. Yavuz S, Ayabakan N, Goncu MT, et al. Effect of combined dopamine and diltiazem on renal function after cardiac surgery. Med Sci Monit. 2002;8:PI45–50. [Google Scholar]
  97. Bergman AS, Odar-Cederlof I, Westman L, et al. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth. 2002;16:294–9. [CrossRef] [Google Scholar]
  98. Darcin OT, Zor MH, Sahin V, et al. Effect of iloprost on renal function in patients undergoing coronary artery bypass grafting: A clinical study. Ann Thorac Cardiovasc Surg. 2013;19:12–7. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.